Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: Feasibility and early results

Clinical Oncology

Volumn 23, Issue 10, 2011, Pages 685-690

  Beriwal, S ^a   Kannan, N ^a   Kim, H ^a   Houser, C ^a   Mogus, R ^a   Sukumvanich, P ^b   Olawaiye, A ^b   Richard, S ^b   Kelley, J L ^b   Edwards, R P ^b   Krivak, T C ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cervix; GEC ESTRO; HDR; Image; MRI

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; IMAGE GUIDED BRACHYTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM; SIGMOID; SURVIVAL RATE; THREE DIMENSIONAL IMAGING; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 80055116114     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.08.007     Document Type: Article

References (28)

1. Dimopoulos J.C., De Vos V., Berger D., et al. Interobserver comparison of target delineation in MRI based cervix cancer brachytherapy according to the GYN GEC-ESTRO recommendations. Radiother Oncol 2007, 83:18-19.
2. Viswanathan A.N., Erickson B.A. Three-dimensional imaging in gynecologic brachytherapy: a survey of the American brachytherapy society. Int J Radiat Oncol Biol Phys 2010, 76:104-109.
3. Pötter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007, 83:148-155.
4. Dimopoulos J.C., Pötter R., Lang S., et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009, 93:311-315.
5. Narayan K., van Dyk S., Bernshaw D., Rajasooriyar C., Kondalsamy-Chennakesavan S. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival. Int J Radiat Oncol Biol Phys 2009, 74:1529-1535.
6. Wang B., Kwon A., Zhu Y., Yeo I., Henson C.F. Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: a single institutional experience with three-dimensional CT-based planning. Brachytherapy 2009, 8:240-247.
7. Tan L.T., Coles C.E., Hart C., Tait E. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 2009, 21:175-182.
8. Chargari C., Magné N., Dumas I., et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 2009, 74:133-139.
9. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO Working Group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
10. Lang S., Nulens A., Briot E., et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 2006, 78:185-193.
11. Georg P., Lang S., Dimopoulos J.C., et al. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2011, 79:356-362.
12. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005, 74:235-245.
13. Van Dyk S., Narayan K., Fisher R., Bernshaw D. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys 2009, 75:64-70.
14. Zwahlen D., Jezioranski J., Chan P., et al. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys 2009, 74(4):1157-1164.
15. Dimopoulos J., De Vos V., Berger D., et al. Interobserver comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Application of the GYN GEC-ESTRO recommendations. Radiother Oncol 2009, 91:166-172.
16. Kim H., Beriwal S., Houser C., Huq S. Dosimetric analysis of 3D image guided HDR brachytherapy planning for the treatment of cervical cancer: is point A based dose prescription still valid in image guided brachytherapy?. Med Dosim 2011, 36:166-170.
17. Pötter R., Kirisits C., Fidarova E.F., et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008, 47:1325-1336.
18. Lindegaard J.C., Tanderup K., Nielsen S.K., Haack S., Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:756-764.
19. De Brabandere M., Mousa A.G., Nulens A., Nulens A., Swinnen A., Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2007, 88:217-226.
20. Beriwal S., Kim H., Coon D., et al. Single magnetic resonance imaging vs magnetic resonance imaging/computer tomography planning in cervical cancer brachytherapy. Clin Oncol (R Coll Radiol) 2009, 21:483-487.
21. Grigsby P.W., Siegel B.A., Dehdashti F., Rader J., Zoberi I. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 2004, 22:2167-2171.
22. Viswanathan A.N., Dimopoulos J., Kirisits C., Berger D., Pötter R. CT- versus MRI-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007, 68:491-498.
23. Kirisits C., Pötter R., Lang S., Dimopoulos J., Wachter-Gerstner N., Georg D. Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer. Int J Radiat Oncol Biol Phys 2005, 62:901-911.
24. Mai J., Erickson B., Rownd J., Gillin M. Comparison of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2001, 51:1131-1141.
25. Petric P., Dimopoulos J., Kirisits C., Berger D., Hudej R., Pötter R. Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 2008, 89:164-171.
26. Narayan K., Barkati M., van Dyk S., Bernshaw D. Image-guided brachytherapy for cervix cancer: from Manchester to Melbourne. Expert Rev Anticancer Ther 2010, 10:41-46.
27. Basic Clinical Radiobiology 2002, 134-146. The linear-quadratic model in clinical practice, Hodder Arnold, London. 3rd ed. S.M. Bentzer, M. Baumann, G.G. Steel (Eds.).
28. Orton C.G. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys 2001, 49:183-189.